发布求助
文献互助 智能选刊 最新文献

Skinmed最新文献

筛选
英文 中文
Editors and Journals: Part III-"Sto Tavo (Who Is In Charge)?" 编辑与期刊：第三部分--"谁说了算？
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
W Clark Lambert, Lawrence Charles Parish, Philip R Cohen, Anthony Gaspari, Claude E Gagna
{"title":"Editors and Journals: Part III-\"<i>Sto Tavo</i> (Who Is In Charge)?\"","authors":"W Clark Lambert, Lawrence Charles Parish, Philip R Cohen, Anthony Gaspari, Claude E Gagna","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Judging whether an editor is good at the job is essential; however, this task may be difficult or even impossible. Several factors are involved, many of which are beyond the control of an editor. We examined some of such situations, which are as follows: (1) Reviewer's abuse of privileged information, in which a reviewer or an associate, who is likely to be a competitor, directs members of their laboratory to rapidly replicate the data and submit the resulting paper in the same or another journal while delaying publication of the submitted paper; (2) defective micromanagement by a stakeholder or owner, such as failure to order paper for the publication of a journal; (3) penny-wise dollar-foolish mismanagement by the owner, such as limiting the figures allowed to an absurdly low number in a dermatology journal (we have a visual specialty); (4) factional abuse, such as when members of a society use a gimmick to exercise outsized influence to effect a change in journal's content, and (5) \"<i>sto tavo</i> (who is in charge)?,\" in which changes in the governance of an ownership society or publisher affect quality of the journal.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple Eruptive Dermatofibromas in Systemic Lupus Erythematosus. 系统性红斑狼疮中的多发性爆发性皮纤维瘤
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
Karl Hoegler, Douglas H Atmatzidis, Amy Weiss, W Clark Lambert
{"title":"Multiple Eruptive Dermatofibromas in Systemic Lupus Erythematosus.","authors":"Karl Hoegler, Douglas H Atmatzidis, Amy Weiss, W Clark Lambert","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Social Media Advice for Dermatologists. 给皮肤科医生的社交媒体建议。
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
Joanne Amy Borg, Sarina Chhoeung, Darbie Naomie Georgiou, Bao Nghi Carita Hau, Tanya Andrea Kossmann Gayan, Shqipe Latifi, Frank Perri, Makayla Petrovski, Alana Marija Sertic, Sara Esperanza Toleldo Velasquez
{"title":"Social Media Advice for Dermatologists.","authors":"Joanne Amy Borg, Sarina Chhoeung, Darbie Naomie Georgiou, Bao Nghi Carita Hau, Tanya Andrea Kossmann Gayan, Shqipe Latifi, Frank Perri, Makayla Petrovski, Alana Marija Sertic, Sara Esperanza Toleldo Velasquez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This study focuses on how skincare professionals, such as dermatologists, plastic surgeons, and dermal clinicians, can apply strategies in publishing credible social media content related to the skin. The study interviewed 10 participants and asked questions about the skincare advice they seek from social media. Analysis of the results revealed the prominent themes of education, delivery of information, credibility, trustworthiness, and relatability; however, visual characteristics of how the information was presented, formed the most significant theme. The risk of the public following advice from nonprofessionals on social media includes miscommunication of ideas and adverse reactions that could result in undesirable outcomes; hence, skincare professionals should include correct advice while producing social media content.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iatrogenic Hypertriglyceridemia when Treating Pityriasis Rubra Pilaris: An algorithm for Monitoring and Treatment during Retinoid Therapy. 治疗皮肤癣时的先天性高甘油三酯血症：维甲酸治疗期间的监测和治疗算法。
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
Casey L Ross, Qiaoli Li, Jouni Uitto, Matthew S Keller, Nicholas A Ross
{"title":"Iatrogenic Hypertriglyceridemia when Treating Pityriasis Rubra Pilaris: An algorithm for Monitoring and Treatment during Retinoid Therapy.","authors":"Casey L Ross, Qiaoli Li, Jouni Uitto, Matthew S Keller, Nicholas A Ross","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unusual Eczematous Dermatitis on the Nipple and Areola in a Young Man with Clear Cell Acanthoma. 一名患有透明细胞棘皮瘤的年轻人的乳头和乳晕上出现异常湿疹性皮炎。
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
Denys Elizabeth Penaloza Daguer, Tatiana Fabiola Ordoñez, Luis Daniel Mazzuoccolo
{"title":"Unusual Eczematous Dermatitis on the Nipple and Areola in a Young Man with Clear Cell Acanthoma.","authors":"Denys Elizabeth Penaloza Daguer, Tatiana Fabiola Ordoñez, Luis Daniel Mazzuoccolo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 24-year-old man with no personal or family history of atopic dermatitis or psoriasis consulted our dermatology department with a desquamating reddish lesion on the left areola and nipple. The lesion, which had developed during the past 4 months, bled occasionally and was treated initially as dermatitis with a combination of topical corticoids and antimicrobials, resulting in partial lessening of the condition. An ultrasound of the skin revealed increased blood flow within the nipple thickening of the dermis. During physical examination, we observed a well-defined desquamating plaque with a slightly shiny surface on the left nipple and areola (Figure 1).</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Particular Crusty Nodule of the Lip. 嘴唇上的特殊结节
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
Anissa Zaouak, Houda Hammami, Samy Fenniche
{"title":"A Particular Crusty Nodule of the Lip.","authors":"Anissa Zaouak, Houda Hammami, Samy Fenniche","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BIMZELX® (Bimekizumab-bkzx) Injection, for Subcutaneous Use. BIMZELX®（Bimekizumab-bkzx）注射液，皮下注射用。
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
Aditya K Gupta, Avantika Mann, Kimberly Vincent, William Abramovits
{"title":"BIMZELX<sup>®</sup> (Bimekizumab-bkzx) Injection, for Subcutaneous Use.","authors":"Aditya K Gupta, Avantika Mann, Kimberly Vincent, William Abramovits","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>BIMZELX<sup>®</sup> (bimekizumab-bkzx) injection, for subcutaneous use, was approved in October 2023 for moderate to severe plaque psoriasis in patients aged ≥18 years. In three phase 3, randomized, double-blind, vehicle, and comparator-controlled studies (Be Vivid, Be Ready, and Be Sure), bimekizumab was investigated for the treatment of plaque psoriasis. The primary efficacy end point was psoriatic area and severity index (PASI) 90 (patients with 90% improvement in PASI from baseline) and investigator's global assessment (IGA) score of 0 (clear skin)-1 (almost clear skin) as well as ≥2-point improvement from baseline at week 16. In the Be Vivid study, patients were randomized into the bimekizumab, placebo, and ustekinumab groups. PASI 90 score was achieved by 85% (273/321) in the bimekizumab group, 5% (4/83) in the placebo group, and 50% (81/163) in the ustekinumab group. IGA 0/1 score was achieved by 84% (270/321) in the bimekizumab group, 5% (4/83) in the placebo group, and 53% (87/163) in the ustekinumab group. In the Be Ready study, patients were randomized into bimekizumab and placebo groups. PASI 90 score was achieved by 91% (317/349) in the bimekizumab group and 1% (1/86) in the placebo group. IGA 0/1 score was achieved by 93% (323/349) in the bimekizumab group and 1% (1/86) in the placebo group. In the Be Sure study, patients were randomized into two bimekizumab groups (receiving different bimekizumab regimens) and one adalimumab group. PASI 90 score was achieved by 86.2% (275/319) in combined bimekizumab groups and 47.2% (75/159) in the adalimumab group. IGA 0/1 score was achieved by 85.3% (272/319) in combined bimekizumab groups and 57.2% (91/159) in the adalimumab group. Bimekizumab was well tolerated with no unexpected safety findings.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Edward L. Keyes Resident Contest for Outstanding Case Reports. Edward L. Keyes 优秀病例报告住院医师竞赛。
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
Vesna M Petronic-Rosic
{"title":"Edward L. Keyes Resident Contest for Outstanding Case Reports.","authors":"Vesna M Petronic-Rosic","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dermatoscopic Radial Rippling of Pigment: A Potential Indicator of Pigmented Bowen's Disease. 皮肤镜下色素的径向波纹：色素性鲍温氏病的潜在指标。
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
Melanie Ngo, Mark M Ash
{"title":"Dermatoscopic Radial Rippling of Pigment: A Potential Indicator of Pigmented Bowen's Disease.","authors":"Melanie Ngo, Mark M Ash","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Pigmented Bowen's disease (pBD) or pigmented squamous cell cancer <i>in situ</i> is uncommon, accounting for 1.67%-5.5% of Bowen's disease lesions. It resembles pigmented actinic keratosis, seborrheic keratosis, solar lentigo, atypical nevus, or melanoma, and is ruled out through biopsy. Pigmented Bowen's disease typically presents as an asymptomatic, flat or slightly raised, scaly, and well-delineated plaque that primarily affects individuals in their sixties. Risk factors include human papilloma virus infection, arsenic exposure, sun exposure, ionizing radiation, and trauma.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The COVID-19-Associated Mucormycosis with Cutaneous Involvement. 与 COVID-19 相关的皮肤受累粘液瘤病。
Skinmed Pub Date : 2024-10-22 eCollection Date: 2024-01-01
Neel Prabha, Ripu Daman Arora, Anju George C, Archana B Wankhade, Ashish Kumar Gupta, Rakesh Kumar Gupta, Nitin M Nagarkar
{"title":"The COVID-19-Associated Mucormycosis with Cutaneous Involvement.","authors":"Neel Prabha, Ripu Daman Arora, Anju George C, Archana B Wankhade, Ashish Kumar Gupta, Rakesh Kumar Gupta, Nitin M Nagarkar","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Mucormycosis is an invasive fungal infection caused by fungi of the order Mucorales. During the coronavirus disease 2019 (COVID-19), a rise in the number of COVID-19-associated mucormycosis (CAM) patients was reported globally. Cutaneous mucormycosis is the third most common presentation of mucormycosis. It is classified as primary cutaneous and secondary cutaneous mucormycosis. The secondary form is more common than the primary cutaneous; however, most reports and case series in the literature are that of primary cutaneous mucormycosis. We accounted a case series of eight patients of CAM with secondary cutaneous mucormycosis.</p>","PeriodicalId":94206,"journal":{"name":"Skinmed","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信